top of page
Media & Press Updates
Emergent Biotechnologies LLC’s CEO and CSO Dr. M. Nasir Uddin has been awarded a NIH SMALL BUSINESS INNOVATION RESEARCH (SBIR) Phase I grant. The grant is in the amount of $384k for one year.
bottom of page
Emergent Biotechnologies LLC’s CEO and CSO Dr. M. Nasir Uddin has been awarded a NIH SMALL BUSINESS INNOVATION RESEARCH (SBIR) Phase I grant. The grant is in the amount of $384k for one year.